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ABSTRACT 
 A majority of American adults in today’s society are treated for anxiety with 
anti-anxiety medications.  Some of these prescribed drugs are neither efficiently 
metabolized by the human body nor removed by wastewater treatment plants 
before they reach streams and rivers and so are often detected in the aquatic 
environment in trace concentrations.  Once present in surface waters, they have 
the potential to cause adverse effects for aquatic organisms, including changes 
in both behavior and brain chemistry.  Previous work has shown that upon 
exposure to 150µg/L fluoxetine, a selective serotonin reuptake inhibitor 
antidepressant, hybrid striped bass (M. saxatilis x M. chrysops) brain serotonin 
levels decreased by almost 50% over six days.  This previous study also 
correlated reduced brain serotonin levels with behavioral alterations that 
decreased an organism’s ecological fitness, specifically the ability of the 
organism to capture its prey.  Similarly, other studies have suggested that 
fluoxetine, along with other anti-anxiety medications, including diazepam and 
buspirone, has the ability to alter an organism’s anxiety behaviors.  However, 
these studies failed to correlate the alteration in behavior with changes in brain 
neurotransmitter levels.  While anxiety medications are designed to alter brain 
neurotransmitter levels, other investigators have suggested that other 
contaminants such as metals can also affect brain chemistry.  A previous study 
has shown that carp exposed to sub-lethal levels of copper over the course of 
iii 
one week experienced decreased brain serotonin levels in three different parts of 
the brain.   
 The current study characterized the effects of ethanol (positive control), 
fluoxetine, diazepam, buspirone, and copper exposure on brain chemistry and 
behavior in the fathead minnow (Pimephales promelas) using the standard light-
dark anxiety behavioral bioassay.  At the onset of the experiment, minnows 
exposed to ethanol, fluoxetine, and copper for one day displayed anxiolytic 
behaviors at lower concentrations.  Longer exposures to buspirone and 
diazepam also elicited anxiolytic behaviors.  Significant decreases in 
neurotransmitter levels were seen after exposure to ethanol, diazepam, and 
copper.  In addition, my study further elucidated the relationship between brain 
chemistry and anxiety behaviors in fish, specifically the relationship between 
brain chemistry and minnow anxiety behavior after exposure to diazepam. 
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CHAPTER ONE: INTRODUCTION 
 A large number of American adults are using prescribed medications to 
treat various anxiety disorders1. As the number continues to increase, concern 
about the concentrations of these medications in the aquatic environment also 
mounts as most major wastewater treatment plants do not effectively remove 
these compounds, which have been detected in many effluents2,3.  Previous 
analytical methods have detected these drugs in the nanogram per liter to 
microgram per liter range in various surface water environments4-6.  In addition to 
anti-anxiety medications and other pharmaceuticals, metals introduced by 
anthropogenic activities are also eliciting concern about the problems increased 
levels may cause in the environment. Copper is a metal both naturally found in 
the earth’s crust and introduced anthropogenically via agricultural and mining 
practices7.  Even present at trace concentrations, these compounds have been 
shown to alter organism behavior8.  These changes in behavior may be linked to 
changes in the brain at sites where these compounds bind to serotonin (5-HT) 
and gamma-aminobutyric acid (GABA) receptors. The binding alters 
neurotransmitter concentrations in the brain, eliciting changes in organism 
behavior which can then lead to population level impacts in the aquatic 
environment.   
 My research focused on the effects of three anti-anxiety drugs (diazepam 
(Fig. 1.1), buspirone (Fig. 1.2), and fluoxetine (Fig. 1.3)) and copper on the brain 
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chemistry and behavior of the fathead minnow (Pimephales promelas).  The 
light-dark behavioral bioassay, a standardized assay used to measure anxiety in 
both mammals and fish, was used to quantify minnow anxiety levels.  Further, 
changes in brain chemistry resulting from exposure to these compounds were 
quantified by extracting the brains of exposed minnows and analyzing them for 
decreases in specific neurotransmitters. The testable hypotheses of my research 
included: 
1. After exposure to either anti-anxiety medications or copper, fathead 
minnows will enter the light side of the tank more often and remain on 
the light side of the tank longer relative to controls.  
2. Levels of 5-HT (Fig. 1.4), 5-hydroxyindoleacetic acid (5-HIAA) (Fig. 
1.5) and GABA (Fig. 1.6) in the fathead minnow brain will decrease 
relative to controls after exposure to anti-anxiety medications and 
copper. 
 This research attempts to fill several gaps in the literature concerning the 
effects of anti-anxiety medications on the fish neurologic system.  The goal of my 
research was to build on previous research conducted in our laboratory by 
examining two additional classes of compounds (i.e. anxiolytics and metals) and 
their effects on fish behavior and brain chemistry.  This goal was achieved 
through completion of the following objectives: 
3 
1. Determine the effects of contaminants on fathead minnow anxiety 
behavior. 
2. Determine the effects of these compounds on fathead minnow brain 
chemistry. 
3. Correlate the changes in fathead minnow anxiety behavior after 
exposure to these compounds with changes in brain monoamine 
concentrations. 
 
Figure 1.1 Chemical structure of diazepam (Valium®). 
 
Figure 1.2 Chemical structure of buspirone (Buspar®). 
 
Figure 1.3 Chemical structure of fluoxetine (Prozac®). 
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Figure 1.4 Chemical structure of serotonin (5-HT). 
 
Figure 1.5 Chemical structure of 5-hydroxyindoleacetic acid (5-HIAA). 
 
Figure 1.6 Chemical structure of gamma-aminobutyric acid (GABA). 
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CHAPTER 2: LITERATURE REVIEW 
Environmental Occurrence of Pharmaceuticals and Anxiolytics 
 Recently, concern has been mounting about the occurrence of 
pharmaceuticals in the aquatic environment and their potential effects on the 
organisms that inhabit it.   Little is known about the behavior and fate of these 
pharmaceuticals once they enter the aquatic environment9.  As such, a 
significant amount of research has been done on pharmaceuticals in the aquatic 
environment.  Concentrations of these drugs have been detected in surface 
waters in the nanogram per liter to microgram per liter range4-6.  Nevertheless, 
even traces of these pharmaceuticals have been shown to alter organismal 
systems and animal behavior8.  In addition, because these pharmaceuticals are 
being released constantly and in mixtures, the potential toxic effects are complex. 
 A proportion of the pharmaceuticals regularly detected in surface waters 
are medications prescribed to treat anxiety.  These can include anxiolytics, drugs 
designed to alleviate anxiety, like diazepam (Valium®), buspirone (Buspar®), and 
chlordiazepoxide (Librium®), or antidepressants, like fluoxetine (Prozac®).  Unlike 
the more widely used pharmaceuticals such as antidepressants and personal 
care products, little research has been performed and much less is known about 
the behavior and fate of anti-anxiety medications once they enter the aquatic 
environment.   
 Human use of these anxiety medications is a major point source through 
which the compounds contained in these medications enter the environment.  
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This source includes both consumption and direct disposal down the toilet9. 
Psychoactive pharmaceuticals, including anxiolytics, are one of the most 
commonly prescribed drug classes on a global scale, and the global annual 
production of these drugs is increasing to meet the demands of consumers5.  
According to the Anxiety and Depression Association of America (ADAA), about 
13.3 million adults in the United States are treated for anxiety disorders, and 
many Americans take anxiety medications without a prescription1.  These 
numbers are only expected to increase with time.  Increases in both production 
and consumption of these drugs can lead to increased concentrations of both 
active and inactive metabolites in surface waters10.  When taken into the body, a 
large majority of these compounds usually do not reach their intended target site 
and so are excreted in the active parent form11.  Those compounds that do reach 
their target sites are neither completely nor efficiently metabolized by the body 
before being excreted as both active and inactive forms10.  These compounds 
enter receiving streams, rivers, and lakes through the effluents of wastewater 
treatment plants that are not equipped to remove them2,3.  They may be modified 
even further by microorganisms during the water treatment process or after, 
sometimes being transformed back into the parent form of the compound12.   
 Once present in aquatic ecosystems, anxiolytics have the potential to 
cause a plethora of adverse effects on the environment and the organisms that 
live there.  Although the concentrations of anxiolytics are usually not high enough 
(due to their relatively short half-lives) to cause a major toxic effect to fish and 
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other aquatic organisms, their continuous entry into the aquatic environment in 
mixtures is cause for concern.  Behavioral changes that disrupt ecological fitness 
may occur due to the highly conserved mode of action of anxiolytics on the brain 
and neurotransmitter receptors.  This situation has spurred much research 
concerning the toxicity of these substances to aquatic organisms.   
Environmental Occurrence of Copper 
 Anti-anxiety medications and other pharmaceuticals are only one class of 
contaminants that are becoming increasingly prevalent in surface waters.  
Another class of contaminants that has the potential to disrupt the aquatic 
environment is metals, specifically copper.  Copper is a naturally occurring metal 
in the Earth’s crust and is found in surface waters as the bioavailable cupric ion 
(Cu2+) where most of it is complexed or associated with organic matter7,13.  
Background concentrations of naturally occurring copper in freshwater systems 
range from 0.2 μg/L to 30 μg/L, but elevated levels as high as 74 μg/L have been 
widely reported14,15.  Copper can also be found naturally in the air, associated 
with airborne particulates as well as in soils, where the mean concentration 
ranges from 5 to 70 mg/kg13.  It is an essential metal required by all organisms in 
low concentrations (5-20 μg/g) with levels exceeding this range considered 
toxic16.   
 In addition to being released naturally by volcanic eruptions, decaying 
vegetation, and forest fires, copper also enters the environment by anthropogenic 
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means including mining, agriculture, and manufacturing activities7.  In 2001, an 
estimated 11,100,000 pounds of copper and 1,000,000,000 pounds of copper-
containing compounds were released into the environment, with 0.4% and 0.04% 
of those totals being released directly into water, respectively13.  It can only be 
assumed that these numbers have increased in more recent years.  Most of the 
copper and copper-containing compounds released from all sources (including 
overburdens from copper mines and tailings, municipal sources, and pesticide 
use) in 2001 was to land (approximately 92% and 99.8% of those totals, 
respectively)13.  Runoff and atmospheric deposition in areas where these 
processes are occurring as well as inefficient removal by wastewater treatment 
plants has caused significant water contamination in certain areas17-19.  For 
example, estimated loading rates into surface waters from agricultural runoff 
ranged from 0.307 to 8.34 mg/hour in one area13.   
 Once present in the aquatic environment, copper can easily bind to 
sediments and organic matter, thus increasing its persistence in the environment 
by becoming complexed to different environmental media.  Bioconcentration can 
then occur in sediment dwelling organisms or be taken up by organisms living in 
the water column where toxic effects can occur, although there is little evidence 
that copper can biomagnify in the food chain13,16.  Nevertheless, even trace 
concentrations of copper have the potential to affect higher organisms.  
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Mode of Action 
Pharmaceuticals and Anxiolytics 
  Antidepressants and anxiolytics affect a number of neurotransmitters in 
the brain, including serotonin and GABA.  These drugs, some of which are 
classified as selective serotonin reuptake inhibitors (SSRIs), can bind to and 
block reuptake transporters for these neurotransmitters (Fig. 2.1).  Reuptake 
transporters are those on the pre-synaptic neuron that reabsorb specific 
neurotransmitters after the neural impulse has been transmitted.  If blocked, the 
reuptake transporters can no longer reabsorb neurotransmitters, leading to an 
increase of those neurotransmitters (serotonin) in the synapses.  Serotonin and 
GABA receptors in the vertebrate brain are highly conserved, and both serotonin 
and GABA play roles in many physiological and behavioral functions in fish20.  
Thus, when present in aquatic environments, these drugs have the potential to 
cause significant alterations in the behavior of aquatic organisms and in turn, 
affect their survival.   
 Anxiolytic compounds work by targeting the brain where they interact with 
neurotransmitter receptors, specifically the serotonin and GABA receptors.  
Serotonin is a monoamine neurotransmitter that is known to regulate mood, 
appetite, and sleep.  Serotonin is found in neurons of organisms from all major 
clades, including vertebrates.  Like other neurotransmitters, serotonin is released 
into the synaptic cleft during neuronal activity and binds to specific receptors, 
where it then elicits a response by activating ion channels to open and allow 
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charged ions through the plasma membrane.  The flow of ions causes a change 
in the transmembrane potential of the neuron, which then sends an excitatory or 
inhibitory signal to the brain and other parts of the body.  Serotonin may also be 
released outside the synapse.  In this case, it exerts a more systemic effect on 
surrounding neurons21.  GABA is thought to be the most important excitatory and 
inhibitory amino acid neurotransmitter in both the central nervous system (CNS) 
and peripheral nervous system (PNS)22and is believed to regulate fear and 
anxiety.  It is widely distributed throughout the brain, found in 30-40% of all 
synapses23.  In vertebrates, GABA binds to specific transmembrane receptors at 
inhibitory synapses in the brain.  The process of ion exchange resulting from the 
binding of GABA is similar to that which results from the binding of serotonin.  
Once bound, ion channels open, causing an influx of negatively charged chloride 
ions into the cell or an efflux of positively charged potassium ions from the cell.  
The flow of ions results in a change in the transmembrane potential of the 
neuron, which ultimately sends an excitatory or inhibitory signal to the brain and 
other parts of the body.    
 As mentioned above, serotonin and GABA are not the only molecules that 
interact with their respective receptor systems.  For example, there are several 
binding sites on the transmembrane GABA receptor including those for 
benzodiazepines, barbiturates, and steroids24.  The mode of action of anxiolytic 
compounds is to interact with the receptor, either as agonists, chemicals that 
bind to a receptor and trigger a response, or as positive allosteric modulators, 
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chemicals that enhance the effect of an agonist.  Diazepam is a positive allosteric 
modulator of GABA while buspirone is a known serotonin receptor agonist.  
Diazepam enhances the effect of GABA by binding to the benzodiazepine site on 
the GABAA receptor and increases the affinity of GABA for its receptor (Fig. 2.2).  
Buspirone is thought to bind preferentially to the 5-HT1A receptor and reduce the 
synthesis and release of serotonin by acting as a partial agonist25 (Fig. 2.3).  
Antagonists may also bind to the receptor, competing with either serotonin or 
GABA for binding and blocking their normal functions. Fluoxetine has been 
shown to bind to 5-HT2C receptors and act as a competitive antagonist74.  In fact, 
some of fluoxetine’s therapeutic effects seem to be linked to this blockage of 5-
HT receptors74.  Studies performed on rats show that blockage of the GABA 
receptor and thus, of the signal, by antagonistic molecules increased anxiety-like 
behavior when the rats were observed in social interaction and conflict tests.  
Additionally, interaction of the GABA receptor with an agonist produced 
anxiolytic-like effects in the rats26.  This mechanism works the same way in 
invertebrates, although GABA receptors in invertebrate organisms are thought to 
have less distinct pharmacological profiles and are less sensitive to some 
chemicals than are vertebrate receptors27.  More is known about the specific 
mechanisms of the GABA receptor in the vertebrate system than in the 
invertebrate system.  Additionally, more research has been performed on the 
mammalian system, which presents a research gap on the GABA receptor 
system in non-mammals, like fish. This is also the case with serotonin, although 
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anxiolytic drugs that act on the mammalian serotonergic system are believed to 
act in a similar manner on fear and anxiety behaviors in fish.  Previous studies 
have confirmed this by measuring increased cortisol levels, an indication of 
activation of the stress axis21.  
 
Figure 2.1 Mode of action of selective serotonin reuptake inhibitors (SSRIs).  
SSRIs, like fluoxetine, can bind to and block reuptake transporters on the pre-
synaptic neuron, thus increasing the concentration of serotonin in the synapse. 
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Figure 2.2 GABA receptor and the binding of GABA.  Diazepam (Valium®) may 
bind to the benzodiazepine site on the GABAA receptor and increase the affinity 
of GABA for the receptor. 
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Figure 2.3 Mode of action of buspirone (Buspar®).  Buspirone may bind to the 5-
HT1A receptor and reduce the synthesis and release of serotonin by acting as an 
agonist. 
Copper  
 Copper is a well-known neurotoxicant and endocrine disruptor and has 
been shown to affect the serotonergic system in several ways.  In fact, the 
serotonergic system in fish has been shown to be sensitive to various forms of 
copper-induced stress28.  As such, exposure to copper can also have an effect 
on certain behavioral responses, although this subject has received much less 
attention29,30.  Some of these behavioral responses can be explained by 
interference in normal function of the olfactory system in fish29,31.  The olfactory 
system of fish is made up of epithelial tissues embedded with ciliated olfactory 
sensory neurons (OSNs).  It is these OSNs that come into contact with the 
surrounding water and so are very sensitive to pollutants in the aquatic 
environment32.  At low concentrations, copper diminishes the responsiveness of 
OSNs, leaving the fish susceptible to predation33. 
 For aqueous copper exposure, the primary target organ is the gill 
epithelium, where copper inhibits the sodium potassium-ATPase (Na+/K+-
ATPase) which leads to ionoregulatory imbalances and gill injury.   Long-term 
exposure to copper can induce stress leading to activation of the hypothalamic-
pituitary-adrenal (HPA) axis and cortisol release.  This stress-induced stimulation 
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eventually results in catecholamine release, which leads to local increases in 
serotonin circulation.  In contrast, studies have shown that dietary copper 
exposure may cause a failure in circulating serotonin.  These opposing effects 
support the importance of route of exposure.  In addition, there is evidence, 
although speculative, that copper affects the metabolism of serotonin, causing 
cross-linking and decreases in serotonin levels34. 
 Although not as frequently studied as pharmaceuticals, metals have also 
been shown to affect monoamine neurotransmitter levels in the brain.  One study 
exposed common carp to aqueous copper in the form of copper nitrate.  The carp 
were exposed for one week. Scientists found dose-dependent decreases in 
serotonin in three different parts of the brain: the telencephalon, hypothalamus, 
and brain stem28.  Lead causes the opposite effect, an increase in serotonin 
levels in the brains of catfish35.  Similarly, when fathead minnows were exposed 
to aqueous lead for four weeks, researchers observed an increase in serotonin 
levels35.  The lack of research that has been performed concerning the effect of 
metals on brain neurotransmitter systems further supports the need for my 
research as a bridge to span the gap. 
The Importance of Behavior as an Endpoint in Ecological Toxicity Testing 
 Behavior is an important and informative endpoint in toxicity testing.   
Much of the concern over an increasing pharmaceutical presence in aquatic 
ecosystems is the effect of these compounds on organismal behavior, even at 
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trace concentrations8.  Because concentrations of pharmaceuticals in the 
environment are usually lower than levels that cause significant acute and 
chronic toxicity, these behavioral endpoints have become quite useful as 
sensitive indicators of pharmaceutical effects on organisms3,8,36,37.   
 To survive, an organism must be able to find and consume food, avoid 
predation, and successfully reproduce to pass on its genes to the next 
generation.  If any of these behaviors is altered, an organism’s chance of survival 
could significantly decline.  Thus, chemicals like anxiolytics and antidepressants 
that alter fear and anxiety responses could potentially interfere with the behavior 
of an organism and cause its fitness to decline.  Exposure may lead to 
anxiogenic-like, or increased anxiety-like behaviors.  Organisms may be too 
anxious to interact socially with other organisms. For example, schooling 
behaviors may change or organisms may become reluctant to leave the safety of 
their shelter to find food and reproduce, negatively affecting their ability to 
survive.  The opposite effect is seen in studies that explore the effects of 
neurotransmitter receptor agonists.  These types of compounds cause an 
increased cellular signal that elicits anxiolytic effects, making organisms less 
anxious over exploring new environments and the approach of other 
organisms26,38.  Organisms may ignore their basic survival instincts and disregard 
an approaching predator.  Copper can affect basic behavioral functions like 
olfaction, or work by interfering with metabolic processes such as the breakdown 
of serotonin in the brain30,34,39.  Because of this effect on serotonin, copper, like 
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anxiolytic drugs, has been hypothesized to affect anxiety behavior.  All of the 
above situations thus have the potential to lead to effects on the population and 
even the ecosystem40. 
 Various studies have investigated the effect of anxiolytics and copper on 
organism behavior in order to determine the sub-lethality of these contaminants.  
Feeding behavior is a common behavioral endpoint in toxicity testing.  After 
exposure to sub-lethal concentrations of SSRI fluoxetine, hybrid striped bass 
exhibited a decrease in ability to capture prey.  This concentration- and time-
dependent decrease was correlated with depressed serotonin levels in the 
brain37.  Similarly, hybrid striped bass exposed to venlafaxine exhibited an 
increased time to capture prey while simultaneously exhibiting decreased brain 
serotonin levels36.  Similar research involved juvenile perch that were exposed to 
sertraline, an SSRI.  The perch exhibited decreased foraging behaviors with 
increasing concentrations of sertraline20.   
 Anxiety behavior is another behavioral endpoint that is commonly tested.  
Researchers exposed zebrafish to fluoxetine, buspirone, and diazepam and 
observed their behavior in the light-dark box scototaxis test.  Chronic treatments 
with fluoxetine increased the time zebrafish spent in the white compartment while 
diazepam and buspirone produced similar effects41.  The ability of fathead 
minnows to avoid predators was investigated after embryos were exposed to 
several common antidepressants at environmentally relevant concentrations, 
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either singularly or in mixtures.  The C-start response, or escape reflex, of 
minnows was adversely affected by exposure to fluoxetine, venlafaxine, and 
bupropion singularly.  Mixtures of these antidepressants also slowed predator 
avoidance behaviors in the minnows42. 
 Reproductive behavior is yet another endpoint used in toxicity testing 
following exposure to pharmaceuticals.  Concentrations of fluoxetine as low as 1 
μg/L significantly affected male mating behaviors, specifically nest building and 
nest defending.  At higher concentrations, males exhibited aggression, isolation, 
and repetitive behaviors43.  Antidepressants have also been found to disrupt the 
reproductive system of molluscs, specifically spawning and larval release.  
Adverse reproductive effects following antidepressant exposure have also been 
discovered in amphipods and daphnids44. 
 Coho salmon that were exposed to increasing, but sub-lethal 
concentrations of copper had an impaired sense of smell to natural odorants 
within 10 minutes of exposure.  Researchers concluded that copper is broadly 
toxic to the salmon olfactory system29.  A second study on copper focused on 
shoaling behavior in killifish.  Shoaling occurs when fish congregate in groups for 
social reasons.  Exposure to acute copper resulted in decreases in time to first 
shoaling and total time spent shoaling30.  The above evidence confirms that 
important behavioral and physiological processes can be affected by chemicals 
in the environment and cause a decline in an organism’s ability to survive, 
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stressing the importance of behavioral endpoints in ecological toxicity testing 
following exposure to environmental contaminants.  
Quantifying Anxiety Behavior in Fish 
 Anxiety behavior is a very useful and informative endpoint that is 
becoming increasingly popular in toxicity testing.  Because it is considered a 
sublethal endpoint, the effects of certain toxicants on this behavior can easily be 
observed and quantified.  As such, several different bioassays have been 
developed to observe and quantify anxiety behavior in both mammals and fish. 
 Zebrafish (Danio rerio) are becoming increasingly promising as a model 
organism for stress and anxiety research.  The potential for the use of this 
species has emerged quite recently.  Zebrafish are useful because they possess 
all of the standard vertebrate neurotransmitters and serve as non-mammalian 
organisms that are physiologically homologous to humans.  In addition, much is 
known about their genome and their neuroendocrine system responds well to 
stress in the form of physiological responses making them a useful species for 
behavioral bioassays45,46.  The two most widely used behavioral assays that 
employ zebrafish as the model organism are the novel tank diving test and the 
light-dark scototaxis test.  The novel tank diving test involves a tank divided into 
sections (top, bottom, etc.) and explores the zebrafish’s instinctual response to 
seek shelter in unfamiliar environments by diving to the bottom of the tank and 
remaining there until the fish feels safe enough to explore.  Researchers assess 
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anxiety by quantifying latency to enter the upper half and time spent in each 
compartment as well as specific behaviors, including erratic movements and 
freezing.  The test relies on an exposure to novelty for quantifying anxiety 
responses in zebrafish, with longer latencies to enter the upper compartment, 
reduced time spent in the top compartment, increased erratic movements, and 
freezing as measures of increased anxiety.  The light-dark scototaxis test, also 
known as the light-dark preference test, is similar in that it also relies on 
exposure to novelty.  However, the tank is divided into equal light and dark or 
white and black compartments.  It has been suggested in a previous study that 
zebrafish prefer a darker environment47 and it is this preference on which the test 
is based.  Entries to the light compartment and time spent in the light 
compartment per entry are quantified with increased entries and more time spent 
in the light compartment being indicative of decreased anxiety behavior.  A third, 
less common behavioral assay is the open field test which consists of a large 
open space divided into inner and outer zones.  The assay relies on the zebrafish 
to display behaviors associated with thigmotaxis, or avoiding the center of a 
novel area and moving in close proximity to the boundaries of said novel area48.  
Variations of these tests have also proven useful for investigating anxiety 
behavior in zebrafish as well as other organisms.   
 Zebrafish are usually exposed to certain anxiolytic or anxiogenic drugs 
before being subjected to one or both of these tests, although researchers have 
investigated the effects of restraint stress on zebrafish behavior instead of 
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chemical exposure48.  These drugs can serve as positive controls for these 
behavioral bioassays, allowing researchers to investigate the effects of other 
compounds not usually used with these assays.  Researchers administered a 
chronic treatment of fluoxetine (100 µg/L) to zebrafish over a period of two weeks 
and observed them in the novel tank diving test.  The exposed fish displayed 
anxiolytic behaviors in the form of lower latency to enter the top compartment, 
more time spent in the top compartment, and a decreased number of erratic 
movements as compared to controls45.   A second study investigated the effects 
of fluoxetine, buspirone, diazepam, and ethanol on zebrafish anxiety behavior 
using the light-dark scototaxis test.  Fish were injected with 5 or 10 mg/kg 
fluoxetine, 25 or 50 mg/kg buspirone, or 0.02 or 0.2 mg/kg diazepam.  Fish 
injected with 10 mg/kg fluoxetine spent more time in the light side of the tank 
while those injected with buspirone spent more time in the light side at both 
doses.  Diazepam-injected fish also showed an anxiolytic effect.  Additionally, 
fish that were exposed to 0.25% ethanol spent more time on the light side of the 
tank41.  Other studies show similar results of anxiolytic compounds decreasing 
anxiety behavior in fish49-51.  The effects of nicotine, cocaine, and caffeine have 
also been investigated using these behavioral tests41,52,53.  Because of the 
validity and plasticity of these behavioral assays, the results may be applied to 
other areas including genetics and medicine, setting the scene for further 
advances in these fields54,55. 
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Quantifying Neurotransmitters in Biological Samples 
  
 Several previous studies have been able to quantify the concentrations of 
neurotransmitters in biological samples from mammals, including humans, and 
from fish.  Methods using various forms of chromatography: gas chromatography 
(GC), high performance liquid chromatography (HPLC), and liquid 
chromatography/tandem mass spectrometry (LC-MS/MS), have reported 
accurate and reliable results for the analysis of neurotransmitters, including 
serotonin and GABA.  One study quantified levels of three monoamine 
neurotransmitters (dopamine, norepinephrine, and serotonin) as well as 
melatonin and its metabolite, 7D-melatonin,  in the brains of sea lampreys 
(Petromyzon marinus) using an LC-MS/MS method with a reversed-phase 
column.  Pre-treatment of samples included solid-phase extraction (SPE) to 
purify and extract the target compounds from samples.  Researchers were able 
to quantify all five compounds with extreme accuracy and limits of detection of 
0.14, 0.09, 0.07 ng/mL for norepinephrine, dopamine, and serotonin, 
respectively.  The same study also investigated the stability of these compounds 
at 4°C in the dark.  Serotonin and dopamine were stable for up to three days and 
one day, respectively, although norepinephrine was not found to be stable under 
these conditions.  In addition, the accuracy of three different types of SPE 
cartridges was tested.  Recoveries were highest for samples that were prepared 
using Bond-Elut C18 cartridges56.  Another study utilized HPLC with fluorescence 
detection to analyze the concentrations of 5-HT and 5-HIAA in sea lamprey 
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plasma samples.  SPE was performed with Oasis HLB cartridges.  Limits of 
detection ranged from 0.04 to 0.13 ng/mL57.  Using an HPLC method with 
electrochemical detection, GABA and dopamine levels were quantified in the 
hypothalamus of largemouth bass (M. salmoides) in the nmol/g range58.  In 
addition to the latter, there have been other studies performed using both whole 
and partial fish brain samples in several different species, including the fathead 
minnow, goldfish, trout, and carp28,59-61.  Finally, one study quantified free GABA 
in the cerebrospinal fluid of humans in the nmol/L range using an isocratic HPLC 
method with electrochemical detection62.   
 With the recent advances in analytical analysis of biological samples, 
neurotransmitter detection methods are becoming more efficient and accurate.  
Researchers developed a method using LC-MS/MS to quantify GABA and 
glutamate in rat brain microdialysis samples with a limit of quantitation of 1 and 
10 nM, respectively.  The use of a hydrophilic interaction liquid chromatography 
(HILIC) column allowed researchers to separate the polar analytes from the 
sample matrix, and thus, the pre-treatment of samples was not required, making 
this method more efficient than previously reported methods.  In addition, when 
compared with previous methods, this method has a higher sensitivity, is more 
selective, and is more rapid with a run time of three minutes23.  A second study 
involving rat microdialysis samples was able to detect GABA and glutamate at 
even lower concentrations (0.03 and 0.8 pmol, respectively).  However, in 
contrast to the previous study, researchers utilized an HPLC method which 
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allowed for detection of very low amounts of these neurotransmitters22.  This 
evidence, along with many other studies, demonstrates the ability of researchers 
to efficiently and accurately quantify neurotransmitter levels in many types of 
biological samples.   
 Although behavioral research after chemical exposure is plentiful, only a 
few studies have actually correlated changes in behavior following chemical 
treatment to changes in brain chemistry in fish21.  Previous research in our lab 
found a negative correlation between time to capture prey and brain serotonin 
activity in hybrid striped bass (M. saxatilis x M. chrysops) after exposure to 
fluoxetine37.  With the completion of this research, I hope to also correlate 
changes in fish behavior, specifically anxiety behavior, and decreases in 
neurotransmitter activity. 
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CHAPTER 3: MATERIALS AND METHODS 
Test Chemicals 
 Methanol, acetonitrile, glacial acetic acid, and triethylamine were all HPLC 
grade and purchased from Fisher Scientific (Fair Lawn, NJ, USA).  The nitric acid 
and hydrochloric acid used to acidify collected water samples were Trace Metal 
Grade and also purchased from Fisher Scientific (Fair Lawn, NJ, USA).  The 
fluoxetine hydrochloride used in all experiments was generously donated by 
Fermion in Finland. Buspirone hydrochloride and copper (II) sulfate pentahydrate 
were purchased from Alfa Aesar (Ward Hill, MA, USA). Absolute ethanol was 
purchased from Aldrich (Ward Hill, MA, USA).  The diazepam was purchased 
from Qualitest Pharmaceuticals (Huntsville, AL, USA) through Godley-Snell 
Research Center (Clemson, SC, USA).  Water used for all analytical procedures 
was passed through a Milli-Q-Super-Q Filtration system (Millipore®, Billerica, MA, 
USA) so that it was ultra-purified and had a measured resistance of 18 mΩ∙cm.  
Exposures were conducted in moderately hard reconstituted water that was 
prepared according to the US EPA recipe: 190 L Millipore® Milli-Q water, 11.4 g 
CaSO4, 11.4 g MgSO4, 0.76 g KCl, and 18.24 g NaHCO363. All salts for 
moderately hard water were purchased from Fisher Scientific (Fair Lawn, NJ, 
USA). Tricaine-S (MS-222) used for euthanizing minnows was purchased from 
Western Chemical (Ferndale, WA, USA. 
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Fish 
 Fathead minnows (Pimephales promelas) were either purchased from I.F. 
Anderson Minnow Farm (Lonoke, AR, USA) or caught in traps that were 
deployed in ponds at the Cherry Farm Aquatic Research Lab at Clemson 
University (Clemson, SC, USA).  The minnows were held in 100 L holding 
troughs that were maintained as flow through systems, supplied with fresh water 
from Lake Hartwell (Clemson, SC, USA) (pH=6.28 ± 0.17, Hardness=24 mg/L as 
CaCO3, Alkalinity=10 mg/L as CaCO3).  The water was filtered and sterilized 
before reaching the holding troughs. Water temperature was maintained within a 
range of 20-27°C.  The water contained within the holding troughs was constantly 
aerated through airstones.  During holding, minnows were fed a commercial diet 
of Tetramin® Tropical Flakes that were purchased from Dr.’s Foster & Smith, Inc. 
(Rhinelander, WI, USA).  Minnows were transported to the Clemson University 
Institute of Environmental Toxicology (Pendleton, SC, USA) for all exposures and 
allowed to acclimate for at least 2 days in a 33 L (20” x 10” x 12 ½“) holding 
aquarium.  The holding aquarium was maintained as a recirculating system with 
a Tetra® Whisper® filter containing Ultra-activated® carbon (Blacksburg, VA, 
USA) and contained moderately hard reconstituted water according to the US 
EPA’s recipe above.  The holding aquarium was constantly aerated using an 
airstone, and minnows were fed the same commercial diet of Tetramin® Tropical 
Flakes purchased from Dr.’s Foster & Smith, Inc. (Rhinelander, WI, USA).  
Minnows chosen for exposures were approximately 5-6 cm in size. 
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Experimental Design 
  
 All exposures were conducted in an animal testing room at the Clemson 
University Institute of Environmental Toxicology (Pendleton, SC, USA).  
Exposure aquaria (2 L, 24 cm x 6.4 cm x 16.5 cm) were half covered with black 
plastic sheeting (Sunbelt Plastics, Monroe, LA, USA) to simulate a “light” 
environment and a “dark” environment (Fig. 3.1).  A clear plastic cover was also 
half covered with the same black plastic sheeting and placed on top of each 
aquarium to prevent minnows from jumping out and also significant evaporation 
of the water.  Each exposure aquarium was aerated with two airstones, one on 
the “light” side and one on the “dark” side to prevent minnows from preferentially 
choosing the side of the tank with the airstone.  Twelve exposure aquaria (n=3 
per treatment) were placed on a metal rack with three shelves so that there were 
four aquaria per shelf (Fig. 3.2).  A white bed sheet was hung behind the metal 
rack to make filming and visual observation of each tank easier.  Volumes of 1.8 
and 0.9 L were measured and marked on each exposure aquarium to indicate 
the fill lines for exposure volume and half renewal volume on half-renewal days, 
respectively.  Concentrations included a low, medium, and high treatment along 
with a control for each chemical and were randomly assigned to each exposure 
aquarium so that there were three replicate exposure aquaria for each of the four 
concentrations.  After the acclimation period, minnows were transferred from the 
33 L holding aquarium to the exposure aquaria so that there was one minnow per 
aquarium.  Each exposure aquarium was spiked with the appropriate amount of 
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drug and subsequently re-spiked with half of the original amount on half renewal 
days according to the half-life of each drug.  Stock solutions of each drug were 
remade for each exposure.  Water samples were taken two hours after the initial 
spike on Day 0 and after each re-spike on renewal days to allow for equilibration.  
Water samples were acidified with the appropriate acid and stored at 4°C until 
further analysis.  Acute exposures lasted for 24 hours while long-term exposures 
lasted for nine days.  Time-points were taken at 30 minutes, 3 hours, 12 hours, 
and 24 hours after exposure for acute exposures and 30 minutes (Day 0), Day 3, 
Day 6, and Day 9 for long-term exposures so that there were a total of four time-
points for each exposure.  Time-points during long-term exposures were taken at 
the same time each day.  For each time-point, minnow behavior was recorded 
with a video camera from outside the animal testing room so as not to disturb the 
minnows.  The number of entries of each minnow to the light side and the 
duration of each entry was recorded.  An “entry” was defined as any time when at 
least half of the minnow body was on the light side of the aquarium.  During 
exposure, minnows were fed the same commercial diet of Tetramin® Tropical 
Flakes every day purchased from Dr.’s Foster & Smith, Inc. (Rhinelander, WI, 
USA).  In addition, water quality measurements (temperature in °C, dissolved 
oxygen in mg/L, alkalinity as CaCO3, hardness as CaCO3, and pH) were 
recorded every day with a YSI™ 556MPS Meter and a ProODO™ Meter (YSI 
Incorporated®, Yellow Springs, OH, USA).  During exposures, the testing room 
was not entered unless absolutely necessary, to avoid influencing the behavior of 
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the minnows.  After the completion of each exposure, minnows were euthanized 
in a solution of MS-222 (Western Chemical, Ferndale, WA, USA), and their 
brains were extracted and stored in a -80°C freezer until further analysis.  Due to 
limited sample size (n=3 per treatment), brains were only extracted after 24 hours 
for acute exposures and after nine days for long-term exposures. 
 
 
Figure 3.1 A single exposure aquarium with the left half covered with black 
plastic sheeting. 
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Figure 3.2 Exposure aquaria setup. 
Diazepam, Buspirone, and Fluoxetine Half-Life Studies 
 The stabilities of diazepam, buspirone, and fluoxetine were investigated to 
determine if subsequent additions of the chemical would be necessary to 
maintain constant concentrations throughout the duration of the experiments.  
Prior to the initiation of exposures, a two-day stability experiment was performed.  
The same experimental setup as described above was used.  A single minnow 
was added to each exposure aquaria to simulate the same conditions as during 
the actual experiment.  Water samples were collected from each aquarium daily 
and measured to determine drug concentrations. 
Ethanol Exposures 
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 Absolute ethanol (Aldrich, Ward Hill, MA, USA) was used as a positive 
control to ensure the validity of the light-dark behavioral bioassay.  In scientific 
experiments, the positive control is a treatment with a known response.  Nominal 
concentrations chosen included 0.25%, 0.5%, and 1.0% (v.v.) along with a 
negative control.  Half water renewals and re-spikes occurred every three days 
for long-term exposures.  Renewals and re-spikes were not performed for acute 
exposures.  
Diazepam, Buspirone, and Fluoxetine Exposures 
 Spiking solutions of diazepam were prepared by dissolving a 10 mg pill in 
10 mL of methanol and placing on a stir plate to equilibrate for 24 hours.  Spiking 
solutions of buspirone and fluoxetine were prepared by dissolving buspirone 
hydrochloride and fluoxetine hydrochloride in methanol.  Concentrations of 
spiking solutions were selected so that there was no more than 0.1mg/L 
methanol in the exposure tanks.  This value is the ASTM recommendation for 
methanol as the carrier solvent73.  The control tanks were spiked with the highest 
volume of methanol that was calculated from desired exposure concentrations to 
ensure there was no toxicity due to the carrier solvent.  Nominal concentrations 
chosen included 35, 75, and 150 μg/L along with the control.  These 
concentrations were chosen because previous research in our lab discovered 
decreases in bass serotonin levels after exposure to similar concentrations of 
fluoxetine36,37.  New spiking solutions were prepared for each exposure.  The 
half-lives of diazepam, buspirone, and fluoxetine were determined to be about 
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one day.  To maintain constant concentrations of these drugs throughout the 
duration of the experiment, re-spikes occurred every day for long-term exposures 
with appropriate volumes of diazepam, buspirone, and fluoxetine spiking 
solutions to reach nominal concentrations.  To prevent the buildup of nitrogenous 
waste products, 50% of the aquaria water was renewed every day prior to re-
spiking.  Aquaria were then re-spiked with the appropriate volume of spiking 
solution, taking into account the half-life of each drug and the volume of water 
removed from the tank.  Renewals and re-spikes were not performed for acute 
exposures.  Water samples were taken two hours after the initial spike on Day 0 
and after each respike on Days 3, 6, and 9 for verification of drug concentrations.  
Water samples were acidified with three drops of 2 M hydrochloric acid and 
stored at 4°C until further analysis.   
Copper Exposures 
 Spiking solutions of copper were prepared by dissolving copper (II) sulfate 
pentahydrate in Milli-Q water.  Nominal concentrations chosen included 20, 40, 
and 80 μg/L.  These concentrations were modeled after previous research that 
observed decreases in brain serotonin levels in three different parts of carp 
brains after exposure to copper28.  Because the carrier solvent for copper was 
Milli-Q water, nothing was added to control tanks.  New spiking solutions were 
prepared for each exposure.  Previous research determined that copper was 
relatively stable in this system and had a half-life of about three days (data not 
shown).  To maintain constant concentrations of copper throughout the duration 
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of the experiment, re-spikes occurred every three days for long-term exposures 
with appropriate volumes of copper spiking solutions to reach nominal 
concentrations.  To prevent the buildup of nitrogenous waste products, 50% of 
the aquaria water was renewed every three days prior to re-spiking.  Aquaria 
were then re-spiked with the appropriate volume of copper spiking solutions, 
taking into account the stability of copper and the volume of water removed from 
the tank.  Renewals and re-spikes were not performed for acute exposures.  
Water samples were taken two hours after the initial spike on Day 0 and after 
each respike on Days 3, 6, and 9 for verification of copper concentrations.  Water 
samples were acidified with nitric acid and stored at 4°C until further analysis.   
Verification of Diazepam, Buspirone, and Fluoxetine Concentrations 
 To confirm exposure concentrations, water samples were taken every day 
prior to re-spiking.  Samples were collected in the appropriate volumetric flask 
and acidified with three drops of 2 M hydrochloric acid.  Samples were extracted 
immediately on 3 mL HyperSep C-18 SPE cartridges with a bed weight of 500 
mg (Thermo Fisher Scientific, Pittsburgh, PA, USA).  Prior to extraction, 
cartridges were conditioned with 3 mL of acetone, 3 mL of methanol, and 6 mL of 
Milli-Q water.  Samples were then loaded onto the cartridges.  After the entire 
sample had passed through the cartridge, the cartridges were dried under 
vacuum for at least 30 minutes.  Cartridges were eluted immediately with a 
solution of methanol and 1% acetic acid.  Elute was collected and stored in 
sample vials at 4°C until HPLC analysis.    
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 The HPLC system consisted of a Waters 1525 Breeze HPLC Pump, a 
Waters 717 Plus auto sampler, a Waters 2475 multi-wavelength fluorescence 
detector, and Waters 2487 multi-wavelength absorbance detector (Waters, 
Milford, MA, USA).  A Varian Polaris 5 C-18A reverse phase analytical column 
(250 mm long, 4.6 mm I.D.) (Varian Inc., Lake Forest, CA, USA) was used to 
achieve chromatographic separation.  The mobile phase for diazepam consisted 
of 60:40 HPLC grade acetonitrile: Milli-Q water adjusted to a pH of ~2 with glacial 
acetic acid and 0.1% triethylamine.  The mobile phase for buspirone consisted of 
35:65 HPLC grade acetonitrile: Milli-Q water adjusted to a pH of ~3 with glacial 
acetic acid and 0.1% triethylamine.  The mobile phase for fluoxetine consisted of 
40:60 HPLC grade acetonitrile: Milli-Q water adjusted to a pH of ~3 with glacial 
acetic acid and 0.4% triethylamine.  All mobile phase solutions were filtered 
through a 0.45 µm nylon filter and degassed for at least 30 minutes using a 
sonication bath.  The flow rate was 1mL/min and a 40 μL injection volume was 
used.  For diazepam, the absorbance detector was set to 238 nm, and the 
retention time was approximately six minutes.  The absorbance detector was set 
to 240 nm for buspirone while the retention time was approximately six minutes.  
For fluoxetine, the fluorescence detector was set at an excitation wavelength of 
270 nm and an emission wavelength of 300 nm.  The retention time for fluoxetine 
was approximately 11 minutes.   
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 Verification of Copper Concentrations 
 To confirm exposure concentrations, water samples were taken every 
three days prior to re-spiking.  Samples were collected in 15mL Falcon tubes 
(VWR International, West Chester, PA, USA), acidified with nitric acid, and stored 
at 4°C until ICP-MS analysis.  
Preparation of Brain Tissue 
 When ready for analysis, brains were collected from storage in -80°C.  
Individual brains were weighed and transferred to new 1.5 mL centrifuge tubes 
(Eppendorf, Westbury, NY, USA).  Brains were homogenized using a 400 W, 20 
kHz Digital-Model 450 Sonifier (Branson, Danbury, CT, USA) in 30 µL of Milli-Q 
at 10% amplitude for five seconds.  Three volumes (90 µL) of cold acetonitrile 
were added to each tube.  Samples were then incubated at -80°C for ~45 
minutes and centrifuged for five minutes at 4°C and 14,000 rpm.  The 
supernatant was collected and incubated for another 45 minutes. Samples were 
centrifuged at the same settings and the supernatant was collected.  Additional 
protein precipitation steps (incubation for ~45 minutes and centrifugation for five 
minutes) were taken if supernatant remained cloudy after the second 
centrifugation.  Once the brain tissue samples were separated from the 
precipitated proteins, the samples were stored at -80°C until LC-MS/MS analysis. 
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Protein Concentration Analysis 
 Brain protein concentrations were measured using a BCA™ Protein Assay 
Kit (Pierce, Rockford, IL, USA).  The diluent for standard curve was 10% 
acetonitrile.  A 10 μL aliquot of each brain sample was diluted 1:10 in Milli-Q 
water before analysis.  A 25 µL aliquot of this solution was then loaded into each 
well.  A volume of 200 µL of working reagent was also added to each well.  
Samples were run in triplicate.  Once the plate had been loaded with all 
standards and samples, it was incubated at 37°C for 30 minutes.  The plate was 
then cooled to room temperature and measured at an absorbance of 526 nm on 
a SpectraMax® 190 microplate reader (Molecular Devices, Sunnyvale, CA, 
USA).  Brain neurotransmitter concentrations were normalized to the observed 
protein concentrations. 
LC-MS/MS Analysis for Neurotransmitters 
 Brain samples were analyzed for 5-HT, 5-HIAA, and GABA using a 
Shimadzu LC-MS/MS 8030 (Kyoto, Japan) equipped with a communications bus 
module (CBM-20A), a degasser (DGU-20A5), a liquid chromatograph (LC-20AT), 
and an auto sampler (SIL-20HT).  The mobile phase consisted of 100% methanol 
and 0.03% formic acid in LC-MS/MS grade water and was run on a gradient 
(Table 3.1).  From 2 to 8 minutes, the flow increased from 5 to 95% methanol, 
from 8 to 11 minutes, the flow remained stable at 95% methanol, and at 11.01 
minutes, the flow decreased to 5% methanol to allow for the instrument to 
recalibrate before the next sample was injected.  The injection volume was set at 
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2 µL.  The run time was 11 minutes.  Retention times for the analyzed 
monoamines were 2.1, 5.5, and 9.5 minutes for 5-HIAA, 5-HT, and GABA, 
respectively. 
Table 3.1 LC-MS/MS mobile phase gradient. 
Time (min) % Methanol 
2 5 
8 95 
11 95 
11.01 5 
 
Data Analysis 
 Behavioral data were analyzed using JMP Pro 10 Statistical Discovery 
software (SAS, Cary, NC, USA).  A model was developed that included terms for 
the fixed effects of drug concentration, time-point, and time-point by 
concentration interaction; and random effects of exposure number, concentration 
by exposure number interaction, and tank nested within exposure number and 
concentration combinations.  ANOVA was used to test the significance of the 
model terms.  If model terms were found to be significant, then Fisher's Protected 
Least Significant Difference test was used to compare the least squares means 
and determine the nature of the effects. 
 Brain neurotransmitter data were also analyzed using JMP Pro 10 
Statistical Discovery software (SAS, Cary, NC, USA).  ANOVA was used to test 
the significance of the linear relationship between concentration and 
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neurotransmitter level.   Then Dunnett’s test was used to compare the means of 
the control groups to the means of the treatment groups.  In addition, behavioral 
and brain neurotransmitter data were log transformed and ANOVA was used to 
test the significance of the behavioral data as a function of the brain 
neurotransmitter data.  
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CHAPTER 4: RESULTS AND DISCUSSION 
Water Quality Measurements 
 Water quality measurements were averaged (mean ± standard deviation) 
for all exposures.  Measurements included pH, temperature, dissolved oxygen, 
alkalinity, and hardness.  The pH, temperature, dissolved oxygen, alkalinity, and 
hardness were 8.04 ± 0.31, 23.15°C ± 0.84, 9.16 mg/L ± 0.48, 52.24 mg/L ± 3.66 
as CaCO3, and 83.69 mg/L ± 5.24 as CaCO3, respectively. 
Diazepam, Buspirone, and Fluoxetine Concentrations 
Diazepam 
 Average diazepam concentrations (mean ± standard deviation) for 
behavioral exposures were 30.49 ± 8.69, 68.87 ± 14.24, and 136.09 ± 33.22 
µg/L.  Nominal diazepam concentrations were set at 35, 75, and 150 µg/L.  
Concentrations remained stable over the course of the exposures.  Diazepam 
concentrations by exposure day are shown in Figure 4.1. 
Buspirone 
 Average buspirone concentrations (mean ± standard deviation) for 
behavioral exposures were 24.90 ± 8.25, 53.43 ± 16.71, and 116.04 ± 39.53 
μg/L.  Nominal buspirone concentrations were set at 35, 75, and 150 μg/L.  
Concentrations remained stable over the course of the exposures.  Buspirone 
concentrations by exposure day are shown in Figure 4.2. 
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Fluoxetine 
 Average fluoxetine concentrations (mean ± standard deviation) for 
behavioral exposures were 20.93 ± 6.49, 53.72 ± 12.46, and 117.22 ± 36.64 
μg/L.  Nominal fluoxetine concentrations were set at 35, 75, and 150 μg/L.  
Concentrations decreased after Day 0, but then remained stable over the 
remaining days of the exposures. Fluoxetine concentrations by exposure day are 
shown in Figure 4.3. 
Copper Concentrations 
 Average copper concentrations (mean ± standard deviation) for behavioral 
exposures were 31.86 ± 5.17, 42.95 ± 6.28, and 79.02 ± 11.34 μg/L.  Nominal 
copper concentrations were set at 20, 40, and 80 μg/L.  Concentrations remained 
stable over the course of the exposures.  Copper concentrations by exposure 
day are shown in Figure 4.4. 
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Figure 4.1 Diazepam concentrations throughout the course of the behavioral 
exposures by exposure day.  Nominal concentrations were 35, 75, and 150 µg/L.  
Error bars represent ±1 standard deviation. 
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Figure 4.2 Buspirone concentrations throughout the course of the behavioral 
exposures by exposure day.  Nominal concentrations were 35, 75, and 150 µg/L.  
Error bars represent ±1 standard deviation. 
0
10
20
30
40
0 3 6 9
35 µg/L
0
20
40
60
80
0 3 6 9
[B
u
sp
ir
o
n
e
] 
(µ
g
/L
)
75 µg/L
0
50
100
150
200
0 3 6 9
Exposure Day
150 µg/L
43 
 
 
Figure 4.3 Fluoxetine concentrations throughout the course of the behavioral 
exposures by exposure day.  Nominal concentrations were 35, 75, and 150 µg/L.  
Error bars represent ±1 standard deviation. 
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Figure 4.4 Copper concentrations throughout the course of the behavioral 
exposures by exposure day.  Nominal concentrations were 20, 40, and 80 µg/L.  
Error bars represent ±1 standard deviation. 
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Qualitative Behavioral Observations 
 
 In addition to the two quantitative endpoints discussed below, qualitative 
observations concerning minnow behavior were also made.  During exposures, 
specifically long-term exposures, minnows seemed less anxious during water 
changes and re-spikes.  Minnows did not flee to the dark side when these events 
were occurring indicating an anxiolytic state.  In addition, “freezing” behavior was 
observed.  Freezing is defined as the complete cessation of movement where 
only the eyes and gill opercula may move.  This behavior has been associated 
with fear and anxiety-inducing stimuli64.  Of the fish that displayed freezing 
behavior, most were either control fish or those exposed to the lowest drug 
concentration which supports the hypothesis that exposure to anxiolytic drugs 
reduces anxiety-like behaviors in fish.  
Ethanol: Behavioral and Brain Chemistry 
 
 After acute exposure to ethanol (positive control, see Ethanol Exposures, 
pg. 30) there were no significant differences among concentrations in number of 
entries into the light side.  There was a significant difference among time-points, 
however.  Number of entries at the 0.5 hr time-point was significantly larger than 
the number of entries at the 24 hr time-point (Fig. 4.5).  While the variability 
among replicates reduced statistical power, the dose-related increase in entries 
into the light side of the tank at the 0.5 hr time-point after treatment is obvious.  
The same trend existed for time spent in the light side of the tank at 0.5 hr after 
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treatment (Fig. 4.6).  Both of these trends disappear at longer exposure times.  
These results suggest that ethanol produces an anxiolytic effect in minnows at 
the onset of exposure, but as time goes on, it has a depressive effect which is 
not surprising since ethanol is a known sedative.  Moreover, as ethanol was the 
positive control for this assay, I expected an anxiolytic effect.  
 After acute ethanol exposure, there were significant decreases in all three 
neurotransmitters measured (Fig. 4.7).  A strong negative correlation was found 
between ethanol concentration and serotonin and 5-HIAA levels (R2=0.8602 and 
0.7054, respectively) although the linear relationships between these 
neurotransmitters and ethanol concentration were not significant (Table 4.1).  
GABA levels decreased in minnows exposed to lower concentrations of ethanol, 
but increased in minnows exposed to the highest concentration.  This 
relationship was found to be significant with a p-value of 0.0471.  As for 5-HIAA, 
minnows had significantly decreased levels after exposure to 1% ethanol.  
Serotonin levels were highest, followed by 5-HIAA and GABA.     
 Minnow GABA and 5-HIAA levels were found to be significantly lower than 
the control after long-term exposure to 0.25 and 0.5% ethanol (Fig. 4.8).  Levels 
of these neurotransmitters increased slightly in minnows after exposure to 1% 
ethanol.  No significant relationships were found between ethanol concentration 
and serotonin levels, although a decreasing trend in these levels was observed.  
Serotonin was found in the highest quantity in minnow brains followed by GABA 
and 5-HIAA.   
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Figure 4.5 Number of entries by minnows to the light side of the tank after acute 
(1 d) exposure to ethanol.  Control = 0%, Low = 0.25%, Medium = 0.5%, High = 
1%. Error bars represent ±1 standard error.  Capital letters represent statistical 
differences among time-points.  Lowercase letters across the top represent 
statistical differences among concentrations.  
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Figure 4.6 Time spent in light by minnows after acute (1 d) exposure to ethanol.  
Control = 0%, Low = 0.25%, Medium = 0.5%, High = 1%. Error bars represent ±1 
standard error.  Capital letters represent statistical differences among time-
points.  Lowercase letters across the top represent statistical differences among 
concentrations. 
 
Figure 4.7 Minnow neurotransmitter concentrations after acute (1 d) exposure to 
0.25, 0.5, and 1% ethanol. Brains were extracted one day after exposure. Error 
bars represent ±1 standard error. Asterisks represent significant difference from 
the control.  Equations and correlation coefficients are shown above and below 
their respective lines. p GABA=0.0471, p 5-HT=0.1385, p 5-HIAA=0.4046. 
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Figure 4.8 Minnow neurotransmitter concentrations after long-term (9 d) 
exposure to 0.25, 0.5, and 1% ethanol. Brains were extracted one day after 
exposure. Error bars represent ±1 standard error. Asterisks represent significant 
difference from the control.    
Table 4.1 P-values and R2 values for neurotransmitter regression lines after 
acute exposure to ethanol. 
Neurotransmitter P-value R2 value  
GABA 0.0471 0.049  
5-HT 0.1385 0.8602  
5-HIAA 0.4046 0.7054  
 
 There were no significant differences in either number of entries or time 
spent on the light side of the tank in the long-term ethanol exposures (Fig. 4.6).  
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Mathur and Guo exposed zebrafish to 0 and 1% ethanol for 8 days (20 min/day) 
and observed their behavior during a withdrawal period.  In contrast to our 
results, zebrafish exposed to 1% ethanol spent more time in the light 
compartment relative to control minnows.  No effect was found on number of 
entries to the light compartment51.  Based on these results, ethanol does not 
have a long-term effect on fathead minnow locomotion or anxiety behavior. 
 A previous study observed a concentration effect on both anxiety and 
locomotion after exposure to ethanol41.  In that study, zebrafish exposed to 0.5% 
ethanol had more midline crossings and spent more time in the light 
compartment relative to control minnows.  A second study found that zebrafish 
exposed to 0.5 and 1% ethanol spent more time in the light compartment 
compared to control fish.  In addition, zebrafish exposed to 1.5% ethanol made 
more entries to the light compartment, but had decreased time spent in the light 
compartment51, which was similar to our results.  However, these studies only 
looked at zebrafish behavior for 15 and 5 minutes each, respectively.  In contrast, 
our study observed minnow behavior for 15 minutes at 4 different time-points 
after exposure.  Further, the second study observed zebrafish during a 
withdrawal period and not in exposure water, as our study did.  We found that 
minnows were more active and spent more time on the light side early in the 
exposure and had decreased activity and time spent in the light compartment at 
later time-points, suggesting an anxiogenic (increase in anxiety) effect of ethanol 
as the experiment proceeded.  Extended exposure to ethanol may have caused 
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depression in the minnows so that as time passed, they became less active and 
did not explore the exposure tank. The fact that previous studies only observed 
fish behavior for a short period of time could explain some of the differences 
between results.     
 In addition, a major difference between my study and previous studies is 
that the latter used zebrafish as a model organism.  The light-dark behavioral 
bioassay was developed using zebrafish46.  However, I used fathead minnows 
because they are a ubiquitous species and thus, more relevant in this context. 
Species differences could be a driving factor causing opposite results in our 
study as compared to others.  Egan et al. observed differences in anxiety 
behaviors between different strains of zebrafish, suggesting a genetic component 
to anxiety behavior45.  Thus, this type of behavior may not translate the same 
way in fathead minnows.  In the future, this experiment could be performed using 
zebrafish to characterize any possible species differences.  
 As depicted in Figure 4.7, there was a trend of dose-dependent decrease 
in brain serotonin levels in response to increasing ethanol concentration.   
However, due to high replicate variability this relationship was not found to be 
statistically significant.  Ethanol is a known positive allosteric modulator of the 
serotonin receptor and has been shown to decrease serotonin levels and affect 
serotonin metabolism68,69.  Hence, I expected an effect of ethanol on serotonin 
levels in the minnow brain.  GABA levels also decreased significantly at 0.5% 
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ethanol.  However, minnows exposed to 1% ethanol had increased GABA levels 
compared to those exposed to 0.5% ethanol.  This finding suggests that there is 
a threshold of ethanol exposure below which GABA levels decrease while above 
which, there was no observable effect on brain GABA concentrations.  Above this 
threshold, GABA receptors could become saturated, leading to an increase in 
circulating GABA levels in the brain.  In contrast to serotonin, this relationship 
was found to be significant (p-value=0.0471), suggesting that GABA levels in 
minnows can be predicted by ethanol exposure.   
 After long-term exposure to ethanol, minnow GABA and 5-HIAA levels 
were found to be significantly lower than the control at lower concentrations but 
increased as ethanol concentration increased thereafter (Fig. 4.8).  A similar 
effect was also seen in GABA levels of minnows exposed to acute ethanol.  
Again, at concentrations higher than 0.5% ethanol, these receptors may become 
saturated, leading to an increase in these neurotransmitter levels in the brain.  
No significant relationships were found between ethanol concentration and 
serotonin levels, although a decreasing trend in these levels was observed which 
parallels the results from our acute exposure studies.  Further, no correlation was 
observed between either of the behavioral endpoints and any of the measured 
neurotransmitter levels.   
Diazepam: Behavior and Brain Chemistry 
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 After acute exposure to diazepam, there was no statistical significance in 
number of entries among concentrations or time-point due to high variability 
among replicates.  However, there was an obvious increase in number of entries 
to the light side by minnows exposed to the two highest concentrations of 
diazepam (Fig. 4.9).  This finding suggests an anxiolytic effect of diazepam at 
higher concentrations.  There was a significant difference in number of entries by 
minnows exposed to 0, 35, and 75 µg/L diazepam long-term (Fig. 4.10).  A large 
decrease in entries occurred in minnows exposed to 35 µg/L diazepam, followed 
by a slight increase in entries at higher concentrations, resulting in a U-shaped 
response.  However, no statistical significance existed among time-points for 
long-term exposure to diazepam.  There were no statistical differences in time 
spent in the light for either acute or long-term diazepam exposures so these data 
are not shown. 
 GABA and 5-HIAA levels decreased following acute diazepam exposure 
(Fig. 4.11).The correlation between diazepam concentration and 5-HIAA levels 
(R2=0.8118) was very strong while a weak negative correlation was found 
between diazepam concentration and GABA levels (R2=0.2759) (Table 4.2).  
There was also a significant increase in serotonin at the lowest concentration of 
diazepam followed by a decrease back to control levels.   
 After long-term exposure to diazepam, both serotonin and 5-HIAA levels 
significantly decreased at 75 µg/L, but levels subsequently increased at the 
highest concentration (Fig. 4.12).  In contrast, there were significantly higher 
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GABA levels in exposed minnows at lower concentrations with a subsequent 
decrease at higher concentrations.  There were no strong correlations observed 
between long-term diazepam exposure and neurotransmitter concentrations.  For 
both acute and long-term exposures, the neurotransmitter found at the highest 
concentrations was 5-HIAA followed by serotonin and GABA.   
 
Figure 4.9 Number of entries by minnows to the light side of the tank after acute 
(1 d) exposure to diazepam.  Control = 0 µg/L, Low = 35 µg/L, Medium = 75 µg/L, 
High = 150 µg/L. Error bars represent ±1 standard error.  Capital letters 
represent statistical differences among time-points.  Lowercase letters across the 
top represent statistical differences among concentrations. 
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Figure 4.10 Number of entries by minnows to the light side of the tank after long-
term (9 d) exposure to diazepam.  Control = 0 µg/L, Low = 35 µg/L, Medium = 75 
µg/L, High = 150 µg/L. Error bars represent ±1 standard error.  Capital letters 
represent statistical differences among time-points.  Lowercase letters across the 
top represent statistical differences among concentrations. 
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Figure 4.11 Minnow neurotransmitter concentrations after acute (1 d) exposure 
to 35, 75, and 150 µg/L diazepam. Brains were extracted one day after exposure. 
Error bars represent ±1 standard error. Asterisks represent significant difference 
from the control.  Equations and correlation coefficients are shown above and 
next to their respective lines. p GABA=0.0730 and p 5-HIAA=0.1581. 
 
Figure 4.12 Minnow neurotransmitter concentrations after long-term (9 d) 
exposure to 35, 75, and 150 µg/L diazepam. Brains were extracted ten days after 
exposure. Error bars represent ±1 standard error. Asterisks represent significant 
difference from the control.   
 
 
0
50
100
150
200
250
300
350
400
450
0 35 75 150
[N
e
u
ro
tr
a
n
sm
it
te
r]
 (
m
g
/g
 p
ro
te
in
)
[Diazepam] (µg/L)
GABA
5-HT
5-HIAA
* *
*
57 
Table 4.2 P-values and R2 values for neurotransmitter regression lines after 
acute exposure to diazepam. 
Neurotransmitter P-value R2 value  
GABA 0.0730 0.2759  
5-HT Not shown Not shown  
5-HIAA 0.1581 0.8118  
 
 After acute exposure to diazepam, there was an obvious increase in 
number of entries to the light side by minnows at 75 µg/L which continued in the 
150 µg/L exposed minnows, suggesting an anxiolytic effect of diazepam on 
minnow behavior (Fig. 4.9).  A threshold effect could explain why only at 75 μ/L 
and above, I found an anxiolytic effect of diazepam on minnow behavior.  
Previous literature supports this finding of an anxiolytic response in that after 
exposure to GABA-enhancing drugs like diazepam, rodents and zebrafish 
displayed anxiolytic behaviors38.  
 There was a significant difference in number of entries by minnows 
exposed to 0, 35, and 75 µg/L diazepam for nine days (Fig 4.10).  A large 
decrease in entries occurred in minnows exposed to 35 µg/L diazepam, followed 
by a slight increase in entries at higher concentrations, suggesting an anxiolytic 
effect of diazepam exposure on a long-term scale on minnow locomotion at 
higher concentrations.  Similar results were observed in a study that subjected 
zebrafish to the novel tank diving test after exposure to diazepam.  More time 
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spent on the bottom of the tank is indicative of increased anxiety.  Although this 
study used higher concentrations of diazepam (from 0.625 to 20 mg/L), they 
observed a U-shaped dose effect on bottom dwelling in zebrafish66.  Low and 
high concentrations as well as the middle concentration did not have an 
anxiolytic effect on bottom dwelling, but moderate concentrations did66.  Our 
results parallel their finding in that a U-shaped dose effect was also observed, 
but with a decrease in entries by control minnows compared to 35 μg/L exposed 
minnows followed by an increase in entries at higher concentrations.    
 Acute diazepam exposure resulted in significant decreases in both 5-HIAA 
and GABA (Fig. 4.11).  A strong negative correlation was observed between 
diazepam concentration and 5-HIAA levels (R2=0.8118) while a weak negative 
correlation was found between diazepam concentration and GABA levels 
(R2=0.2759) (Table 4.2).  Diazepam is a positive allosteric modulator of GABA 
type A (GABAA) receptors.  Binding of diazepam to these receptors promotes the 
binding of GABA and GABA-enhancing effects.  The enhancement of the GABA-
ergic system has been shown to induce anxiolytic effects in several species by 
inhibiting all other neurotransmitters38.   
 After a longer exposure to diazepam, both serotonin and 5-HIAA levels 
significantly decreased at 75 µg/L, but levels increased in minnows exposed to 
the highest concentration (Fig. 4.12).  In contrast, there were significantly higher 
GABA levels in exposed minnows than in control minnows at lower 
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concentrations of diazepam, but a subsequent decrease in GABA levels at higher 
concentrations, although this decrease was not significant.  Because of a lack of 
strong correlations observed between long-term diazepam exposure and 
neurotransmitter concentrations, I speculate that long-term exposure to 
diazepam may not have much of an effect on GABA levels in the brain.  This 
relationship provides more insight to the interaction between diazepam and the 
GABA-ergic system.  
 My study is the only one in the literature that measured neurotransmitter 
levels after exposure to diazepam.  Thus, it can begin to fill the gap in the area of 
altered brain chemistry after exposure to anxiolytics.  Further, significant 
correlations were observed between both behavioral endpoints and measured 
neurotransmitter levels, discussed below. 
Buspirone: Behavioral and Brain Chemistry 
 
 After exposure to acute buspirone, there was no statistical significance 
among concentrations for number of entries and no apparent trends among 
timepoints either (Fig. 4.13).  After long-term exposure to buspirone, there was 
no statistical significance among concentrations or time-points for number of 
entries due to high variability among replicates.  However, there was a noticeable 
trend of more entries to the light side of the tank at lower concentrations 
compared to higher concentrations (Fig. 4.14).   
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 Minnows subjected to an acute exposure to buspirone spent significantly 
more time on the light side of the tank compared to control minnows (Fig. 4.15).  
This anxiolytic effect of buspirone was immediately apparent.  There was also a 
significant increase in the amount of time that minnows spent on the light side at 
time-points after 0.5 hours, again suggestive of an anxiolytic effect at higher 
concentrations.   
 More definitive results were seen after long-term exposure to buspirone. 
There was a statistically significant decrease in the time that minnows spent in 
the light when compared to control minnows, except in minnows exposed to 75 
µg/L buspirone at the Day 0 time-point (Fig. 4.16).  These results suggest a 
depressive effect of buspirone upon longer exposure. 
 After acute exposure to buspirone, there was a dose-dependent decrease 
in serotonin, with an R2 value of 0.7079 (Fig. 4.17 and Table 4.3).  Minnows 
exposed to the higher concentrations of buspirone had significantly lower levels 
of serotonin than control minnows.  In contrast, 5-HIAA levels increased with a 
peak at 75 µg/L buspirone followed by a return to control levels at 150 µg/L.  
Long-term exposure to buspirone yielded a dose-dependent increase in GABA, 
with an R2 value of 0.7997 (Fig. 4.18 and Table 4.4).  There were no significant 
differences in measured serotonin or 5-HIAA levels when compared to controls.  
After both acute and long-term exposure to buspirone, 5-HIAA was the 
neurotransmitter with the highest levels in the brain followed by serotonin and 
GABA.   
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Figure 4.13 Number of entries by minnows to the light side of the tank after 
acute (1 d) exposure to buspirone.  Control = 0 µg/L, Low = 35 µg/L, Medium = 
75 µg/L, High = 150 µg/L. Error bars represent ±1 standard error.  Capital letters 
represent statistical differences among time-points.  Lowercase letters across the 
top represent statistical differences among concentrations. 
0
5
10
15
20
25
30
35
40
Control Low Medium High
N
u
m
b
e
r 
o
f 
E
n
tr
ie
s
Buspirone Treatment)
0.5 hours
3 hours
12 hours
24 hours
a aaa
B
A 
AB 
AB 
62 
 
 
Figure 4.14 Number of entries by minnows to the light side of the tank after long-
term (9 d) exposure to buspirone.  Control = 0 µg/L, Low = 35 µg/L, Medium = 75 
µg/L, High = 150 µg/L. Error bars represent ±1 standard error.  Capital letters 
represent statistical differences among time-points.  Lowercase letters across the 
top represent statistical differences among concentrations. 
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Figure 4.15 Time spent in light by minnows after acute (1 d) exposure to 
buspirone. Control = 0 µg/L, Low = 35 µg/L, Medium = 75 µg/L, High = 150 µg/L. 
Error bars represent ±1 standard error.  Capital letters represent statistical 
differences among time-points.  Lowercase letters across the top represent 
statistical differences among concentrations. 
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Figure 4.16 Time spent in light by minnows after long-term (9 d) exposure to 
buspirone. Control = 0 µg/L, Low = 35 µg/L, Medium = 75 µg/L, High = 150 µg/L. 
Error bars represent ±1 standard error.  Capital letters represent statistical 
differences among time-points.  Lowercase letters across the top represent 
statistical differences among concentrations. 
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Figure 4.17 Minnow neurotransmitter concentrations after acute (1 d) exposure 
to 35, 75, and 150 µg/L buspirone. Brains were extracted one day after exposure. 
Error bars represent ±1 standard error. Asterisks represent significant difference 
from the control.  Equation and correlation coefficient are shown above their 
respective line. p 5-HT=0.3941. 
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Figure 4.18 Minnow neurotransmitter concentrations after long-term (9 d) 
exposure to 35, 75, and 150 µg/L buspirone. Brains were extracted ten days after 
exposure. Error bars represent ±1 standard error. Asterisks represent significant 
difference from the control.  Equation and correlation coefficient are shown next 
to their respective line. p GABA=0.4098. 
Table 4.3 P-values and R2 values for neurotransmitter regression lines after 
acute exposure to buspirone. 
Neurotransmitter P-value R2 value  
GABA Not shown Not shown  
5-HT 0.3941 0.7079  
5-HIAA Not shown Not shown  
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Table 4.4 P-values and R2 values for neurotransmitter regression lines after long-
term exposure to buspirone. 
Neurotransmitter P-value R2 value  
GABA 0.4098 0.7997  
5-HT Not shown Not shown  
5-HIAA Not shown Not shown  
 
 After exposure to acute buspirone, I found no statistical significance 
among concentrations for number of entries (Fig. 4.13).  These results parallel 
another study in which zebrafish were injected with buspirone and researchers 
found no observable effect of buspirone dose on locomotion41.   
 After exposure to long-term buspirone, there was no statistical significance 
among concentrations or time-points for number of entries (Fig. 4.14).  However, 
there does seem to be a noticeable trend present.  There were more entries at 
lower concentrations as compared to higher concentrations.  Although not 
significant due to high variability among replicates, the observation suggests that 
at lower concentrations, long-term exposure to buspirone had an anxiolytic effect 
on minnows.  As concentrations increased, minnows were less active and less 
willing to explore the tank.  Alternatively, minnows could become tolerant to 
buspirone at higher concentrations, and so are not affected by the drug as much 
and do not enter the light side as often.   
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 There was a significant and immediate increase in time spent on the light 
side by exposed minnows as compared to control minnows after acute exposure 
to buspirone (Fig. 4.15).  This observation indicates that minnows were less 
anxious to explore the light side of the tank, suggesting that buspirone had an 
anxiolytic effect on the minnow’s preference for the light side of the tank.  
Maximino et al. found similar results as zebrafish in their experiment exhibited a 
dose dependent increase in time spent in the light compartment41.  Connors et al. 
also found similar results: zebrafish exposed to higher concentrations of 
buspirone spent far more time in the white compartment when compared to 
minnows exposed to lower concentrations50.  My study found a significant 
increase in the amount of time that minnows spent on the light side at time-points 
after 0.5 hours, again suggestive of an anxiolytic effect of buspirone. 
 In contrast, after long-term exposure to buspirone, there was a statistically 
significant decrease in the time that minnows spent in the light when compared to 
control minnows, except in minnows exposed to 75 µg/L buspirone at the Day 0 
time-point, where time spent in light increased again (Fig. 4.16).  This finding 
parallels the entry data after long-term exposure to buspirone discussed above.   
Thus, exposure to long-term buspirone may cause a depressive effect in 
minnows resulting in less time spent in the light.   
 As Figure 4.17 shows, a dose-dependent decrease in serotonin levels 
after acute exposure to buspirone occurred.  An R2 value of 0.7079 indicated that 
buspirone exposure is a strong predictor of serotonin levels, although the p-value 
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of regression (0.3941) was not significant (Table 4.3).  The result was expected 
because buspirone is a known serotonin receptor agonist that reduces the 
synthesis and release of serotonin in the brain25.  In contrast, a significant 
increase in 5-HIAA levels was found in minnows after exposure to 75 µg/L 
buspirone.  Because 5-HIAA is a metabolite of serotonin, I would expect an 
increase in 5-HIAA as serotonin levels decrease.   
 In contrast to the acute exposure, long-term exposure to buspirone yielded 
a dose-dependent increase in measured GABA levels although the change was 
not found to be statistically significant (Fig. 4.18 and Table 4.4).  Further, no 
correlation was observed between either of the behavioral endpoints and any of 
the measured neurotransmitter levels.  My study is the only one in the literature 
that measured neurotransmitter levels after exposure to buspirone, it serves as a 
stepping stone for future studies. 
Fluoxetine: Behavior and Brain Chemistry 
 
 After acute exposure to fluoxetine, minnows entered the light side of the 
exposure tank more than control minnows.  The trend was most obvious at 0.5 
and 24 hours after exposure (Fig. 4.19).  While high variability among replicates 
reduced statistical power, a dose-related decrease in entries to the light side of 
the tank is apparent.     
 After acute exposure to 35 µg/L fluoxetine, minnows spent less time on 
the light side of the tank than control minnows (Fig. 4.20).  The time spent in the 
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light for minnows exposed to 35 µg/L fluoxetine was statistically less than that of 
all other minnows.  At concentrations higher than 35 µg/L fluoxetine, the time 
spent in the light increased to that of control minnows.  Differences in time spent 
in the light at each time-point were not significant.  After long-term exposure to 
fluoxetine, there were no statistical differences in either behavioral measure, and 
so those data are not shown.    
 Acute exposure to 35 µg/L fluoxetine significantly decreased GABA levels 
in minnows (Fig. 4.21).  However, these levels were increased after exposure to 
a higher concentration of fluoxetine.  The same positive trend was observed in 
serotonin and 5-HIAA levels.  Minnows exposed to 35 μg/L fluoxetine on a long-
term scale had significantly decreased serotonin levels (Fig. 4.22).  However, 
these levels significantly increased after exposure to 75 μg/L and remained 
higher than control minnow serotonin levels after exposure to150 μg/L.  Again, 
the same positive trend was observed with GABA and 5-HIAA levels, results that 
paralleled what I observed in the acute exposures.  Following both acute and 
long-term exposure to fluoxetine, serotonin was found in the highest quantity 
followed by 5-HIAA and GABA.   
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Figure 4.19 Number of entries by minnows to the light side of the tank after 
acute (1 d) exposure to fluoxetine.  Control = 0 µg/L, Low = 35 µg/L, Medium = 
75 µg/L, High = 150 µg/L. Error bars represent ±1 standard error.  Capital letters 
represent statistical differences among time-points.  Lowercase letters across the 
top represent statistical differences among concentrations. 
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Figure 4.20 Time spent in light by minnows after acute (1 d) exposure to 
fluoxetine. Control = 0 µg/L, Low = 35 µg/L, Medium = 75 µg/L, High = 150 µg/L.   
Error bars represent ±1 standard error.  Capital letters represent statistical 
differences among time-points.  Lowercase letters across the top represent 
statistical differences among concentrations. 
 
 
 
 
 
 
 
Figure 4.21 Minnow neurotransmitter concentrations after acute (1 d) exposure 
to 35, 75, and 150 µg/L fluoxetine. Brains were extracted one day after exposure. 
Error bars represent ±1 standard error. Asterisks represent significant difference 
from the control.   
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Figure 4.22 Minnow neurotransmitter concentrations after long-term (9 d) 
exposure to 35, 75, and 150 µg/L fluoxetine. Brains were extracted one day after 
exposure. Error bars represent ±1 standard error. Asterisks represent significant 
difference from the control.   
 Fluoxetine is one of the most studied medications in terms of its effect on 
organism behavior as evidenced by the plethora of research in the past 
decade37,38,41,45,55.  The conclusion from the majority of the research is that 
exposure to fluoxetine causes anxiolytic effects in fish.  One of these studies 
exposed zebrafish to 100 μg/L fluoxetine for 2 weeks and observed their 
behavior in the novel tank diving test45.  Fluoxetine was shown to cause robust 
anxiolytic effects in the zebrafish, including increased exploration and reduced 
erratic movements45.  A second experiment subjected zebrafish to the light-dark 
scototaxis test after injection with either 5 or 10 mg/kg fluoxetine41.  Researchers 
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observed altered locomotion and more time spent in the light compartment by 
zebrafish at the highest dose after chronic injection with fluoxetine41.  However, 
fluoxetine was found to have no effect on zebrafish behavior after 20 minutes of 
exposure38.   
 After acute exposure to fluoxetine, we observed that minnows entered the 
light side of the exposure tank more than control minnows (Fig. 4.19).  The trend 
was most apparent at 0.5 and 24 hours after exposure, although it was not found 
to be statistically significant due to high variability among replicates.  These 
results parallel previous studies that observed anxiolytic behaviors in zebrafish 
after fluoxetine treatment.  However, at higher concentrations of fluoxetine, a 
decrease in entries was observed.  As Figure 4.20 depicts, after acute exposure 
to 35 µg/L fluoxetine, minnows spent significantly less time on the light side of the 
tank than control minnows.  At concentrations higher than 35 µg/L fluoxetine, the 
time spent in the light increased to that of control minnows.   
 In contrast with previous studies, I found a decreasing trend in anxiolytic 
behaviors, specifically minnow entries, after exposure.  These differences 
between my research and previous research could be explained by species 
differences, differences in route of exposure, and differences in the duration of 
exposure and observation periods.  Previous studies exposed zebrafish to 
fluoxetine for a shorter period of time than my study as well as observed them for 
a shorter period of time.  A shorter exposure and observation period would 
explain why I observed an anxiolytic effect at the beginning of the experiment 
75 
followed by a decrease in entries over the course of the experiment.  In addition, 
injection of the drug is a faster route of exposure than simple waterborne 
immersion and thus, the effects of the drug would manifest themselves more 
rapidly after injection.    
 I did not find any significant effects of long-term fluoxetine treatment on 
minnow anxiety behavior although several past studies have documented an 
anxiolytic effect after two weeks of fluoxetine treatment45.  Again, the difference 
could be attributed to species differences as well as differences in route of 
exposure and duration of exposure/observation periods.  
 After acute exposure to fluoxetine, neurotransmitters reached their 
maximum level at 75 µg/L and subsequently decreased to levels similar to those 
of controls (Fig. 4.21).  These results do not parallel previous results from our lab 
or other studies performed as I observed an increase in all neurotransmitter 
concentrations when compared to the controls.  After exposure to the other 
compounds in my study, there were observable decreases in brain 
neurotransmitter concentrations.  A previous study also reported decreased 
serotonin levels in hybrid striped bass after exposure to the same concentrations 
of fluoxetine for six days37.  The most obvious difference between the conflicting 
results is the species of fish used.  It may be that fathead minnows respond 
differently to fluoxetine exposure compared to larger fish species such as the 
hybrid striped bass.  
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 As depicted in Figure 4.22, minnows exposed to 35 μg/L fluoxetine on a 
long-term scale had significantly decreased serotonin levels.  However, these 
levels significantly increased after exposure to higher concentrations of fluoxetine 
and remained higher than control levels at the highest concentration.  The same 
trend was observed with GABA and 5-HIAA levels and also, paralleled what I 
observed after acute exposure to fluoxetine.  After chronic treatment with SSRIs, 
antidepressant effects such as a rise in serotonin levels have been reported71,72 
which could explain my observations of increased neurotransmitter levels in 
minnow brains as minnows were exposed to fluoxetine for nine days, much 
longer than previous literature reports.  Moreover, despite increases in all 
neurotransmitters, serotonin levels were most affected by fluoxetine treatment 
which was expected as fluoxetine is a known SSRI.  Further, no correlation was 
observed between either of the behavioral endpoints and any of the measured 
neurotransmitter levels. 
Copper: Behavioral and Brain Chemistry  
 
 After acute exposure to copper, there was an increasing trend in entries to 
the light side of the tank at and above 40 µg/L (Fig. 4.23).  However, due to high 
variability among replicates, the trend was not statistically significant.  Minnows 
exposed to these concentrations entered the light side more than control 
minnows and those minnows exposed to the lowest concentration of copper.  
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Moreover, in regards to time spent in the light, there was a significant difference 
among time-points, specifically 12 and 24 hours after exposure (Fig. 4.24).   
 There were no statistical differences in the long-term exposures in either 
number of entries or time spent in the light.  Thus, I conclude that copper does 
not have a long-term effect on fathead minnow anxiety behavior.  My study, as 
far as I know, is the only study to investigate the effects of copper exposure, both 
on an acute and long-term scale, on anxiety behavior in fathead minnows.   
 A strong negative correlation was found between copper concentration 
and all neurotransmitter levels after an acute exposure (Fig. 4.25).  5-HIAA levels 
were significantly decreased at 20 µ/L, GABA levels at 20 µg/L, and serotonin 
levels at the highest concentration, which was 80 µg/L.  The neurotransmitter 
found in the highest quantity was 5-HIAA followed by serotonin and GABA.  After 
long-term exposure to copper, however, only GABA and serotonin levels were 
significantly decreased when compared to controls (Fig. 4.26).  Moreover, a 
strong negative correlation was found between copper concentration and 
serotonin and GABA concentrations (R2=0.7257 and 0.9645, respectively) (Table 
4.6). The relationship between serotonin levels and copper concentration was 
found to be statistically significant (p=0.0311).   
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Figure 4.23 Number of entries by minnows to the light side of the tank after 
acute (1 d) exposure to copper. Control = 0 µg/L, Low = 20 µg/L, Medium = 40 
µg/L, High = 80 µg/L. Error bars represent ±1 standard error. Capital letters 
represent statistical differences among time-points.  Lowercase letters across the 
top represent statistical differences among concentrations. 
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Figure 4.24 Time spent in light by minnows after acute (1 d) exposure to copper.  
Control = 0 µg/L, Low = 20 µg/L, Medium = 40 µg/L, High = 80 µg/L. Error bars 
represent ±1 standard error.  Capital letters represent statistical differences 
among time-points.  Lowercase letters across the top represent statistical 
differences among concentrations. 
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Figure 4.25 Minnow neurotransmitter concentrations after acute (1 d) exposure 
to 20, 40, and 80 µg/L copper. Brains were extracted one day after exposure. 
Error bars represent ±1 standard error. Asterisks represent significant difference 
from the control.  Equations and correlation coefficients are shown above and 
below their respective lines. p GABA=0.1111, p 5-HT=0.5598, p 5-HIAA=0.1088. 
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Figure 4.26 Minnow neurotransmitter concentrations after long-term (9 d) 
exposure to 20, 40, and 80 µ/L copper. Brains were extracted ten days after 
exposure. Error bars represent ±1 standard error. Asterisks represent significant 
difference from the control.  Equations and correlation coefficients are shown 
above and next to their respective lines. p GABA=0.5390, p 5-HT=0.0311, p 5-
HIAA=0.1921. 
Table 4.5 P-values and R2 values for neurotransmitter regression lines after 
acute exposure to copper. 
Neurotransmitter P-value R2 value  
GABA 0.1111 0.7393  
5-HT 0.5598 0.7569  
5-HIAA 0.1088 0.4624  
y = -0.0338x + 7.7148
R² = 0.9645
y = -0.0508x + 7.6546
R² = 0.7257
y = -0.1093x + 36.742
R² = 0.3259
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Table 4.6 P-values and R2 values for neurotransmitter regression lines after long-
term exposure to copper. 
Neurotransmitter P-value R2 value  
GABA 0.5390 0.9645  
5-HT 0.0311 0.7257  
5-HIAA 0.1921 0.3259  
 
 After acute exposure to copper, there was an increasing trend in entries to 
the light side of the tank in minnows exposed to higher concentrations of copper 
(Fig. 4.23).  Minnows exposed to lower concentrations of copper entered the light 
side of the tank less often than those minnows exposed to higher concentrations.  
A proposed mode of action for copper is interference with the olfactory sensory 
neurons that are embedded in fish epithelial tissue32.  This interference can 
cause alterations in predator avoidance behavior of prey so that prey fish cannot 
sense that a predator is near and has been shown to alter fish preference for the 
light or dark side in behavioral testing33.  If the olfactory sense is affected 
negatively by copper, fish may behave differently and enter the environment that, 
innately, they do not prefer, possibly making them susceptible to a predator.   
 In addition, my results support the conclusion of a threshold of copper at 
40 μg/L such that until this critical concentration is reached, fish prefer the dark 
side of the tank. Moreover, in regards to time spent in the light, there was a 
significant difference among time-points, specifically 12 and 24 hours after 
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exposure.  Exposed minnows spent more time on the light side of the tank after 
the 24 hr time-point than the 12 hr time-point (Fig. 4.24), suggesting a threshold 
of exposure time as well.   
 As depicted in Figure 4.25, a strong negative correlation was found 
between copper concentration and neurotransmitter levels.  5-HIAA levels were 
significantly decreased at 20 µ/L, GABA levels at 20 µg/L, and serotonin levels at 
the highest concentration, 80 µg/L, with R2 values of 0.4624, 0.7393, and 0.7569 
for 5-HIAA, GABA, and serotonin, respectively (Table 4.5).  Thus it seems that 
copper concentration would be a good predictor of brain neurotransmitter levels.  
These results were expected because it has been proposed that copper affects 
both the HPA access and serotonin metabolism in the brain by causing cross-
linking between molecules34,70.  These decreased neurotransmitter levels may 
cause differences in fish behavior, leaving them more susceptible to predation.    
 After long-term exposure to copper, significant decreases were seen in 
serotonin levels of exposed minnows (Fig. 4.26).  Moreover, GABA levels in 
exposed minnows also decreased relative to controls.  A strong negative 
correlation was observed between long-term exposure to copper and 
neurotransmitter concentrations, specifically serotonin and GABA (R2=0.7257 
and 0.9645, respectively) (Table 4.6).  These correlation coefficients suggest that 
copper concentration is a good predictor of serotonin and GABA levels in the 
brain on a long-term scale.  Additionally, I found a significant linear relationship 
84 
between copper concentration and serotonin levels (p=0.0311) which adds to my 
conclusion that exposure to copper on a long-term scale decreases serotonin 
levels in minnow brains.   
 My long-term results parallel a previous study that exposed juvenile carp 
to sub-lethal levels of copper for one week28.  Researchers observed a dose-
dependent decrease in serotonin levels in three different parts of the brain: the 
hypothalamus, the tencephalon, and the brain stem.  In addition, they observed 
no significant changes in 5-HIAA28, also parallel to my study, where the R2 value 
for 5-HIAA levels versus copper concentration was 0.2119.  Thus, I conclude that 
long-term copper concentration does not affect 5-HIAA levels in the brain, and is 
not a good predictor of this endpoint.  Because 5-HIAA levels were found to be 
decreased after acute exposure to copper, but fluctuated after long-term 
exposure, I speculate that these receptors become tolerant, and thus, copper 
does not have as much of an effect in the long-term.  Further, no correlation was 
observed between either of the behavioral endpoints and any of the measured 
neurotransmitter levels.       
Linking Behavior with Brain Chemistry 
 When plotted on a log-log plot, there was a strong negative relationship 
between both number of entries into the light side and the time spent on the light 
side of the tank and measured GABA concentrations after acute diazepam 
exposure.  Variability among replicates resulted in p-values that were not 
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considered statistically significant (p=0.0635 and 0.0514, respectively).  
Nevertheless, an obvious relationship is present.  A weak, negative correlation 
was observed for both of these relationships with R2  values of 0.148 and 0.1617, 
respectively. 
 When plotted on a log-log plot, there was a significant relationship 
between both the number of entries into the light side and the time spent on the 
light side of the tank and measured 5-HIAA concentrations after acute diazepam 
exposure with p values of 0.0274 and 0.0148, respectively (Figs. 4.29 and 4.30).  
A weak, negative correlation was observed for both of these relationships 
(R2=0.2023 and 0.2412, respectively).   
 A significant relationship was observed between both the log number of 
entries and log time spent in the light and log [serotonin] after long-term 
diazepam exposure (Figs. 4.31 and 4.32).  The p-values were 0.0255 and 
0.0409, respectively.  Both of these positive relationships were found to be 
weakly correlated (R2=0.2159 and 0.1843, respectively).   
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Figure 4.27 Double log plot of fish behavior (number of entries into the light side 
of the tank) as a function of measured GABA concentrations after acute (1 d) 
diazepam exposure. The equation and correlation coefficient are depicted. 
p=0.0635. 
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Figure 4.28 Double log plot of fish behavior (time spent on the light side of the 
tank) as a function of measured GABA concentrations after acute (1 d) diazepam 
exposure. The equation and correlation coefficient are depicted. p=0.0514. 
 
Figure 4.29 Double log plot of fish behavior (number of entries into the light side 
of the tank) as a function of measured 5-HIAA concentrations after acute (1 d) 
diazepam exposure.  The equation and correlation coefficient are depicted. 
p=0.0274. 
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Figure 4.30 Double log plot of fish behavior (time spent on the light side of the 
tank) as a function of measured 5-HIAA concentrations after acute (1 d) 
diazepam exposure.  The equation and correlation coefficient are depicted. 
p=0.0148. 
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Figure 4.31 Double log plot of fish behavior (number of entries into the light side 
of the tank) as a function of measured serotonin (5-HT) concentrations after long-
term (9 d) diazepam exposure.  The equation and correlation coefficient are 
depicted. p=0.0255. 
 
Figure 4.32 Double log plot of fish behavior (time spent on the light side of the 
tank) as a function of measured serotonin (5-HT) concentrations after long-term 
(9 d) diazepam exposure.  The equation and correlation coefficient are depicted. 
p=0.0409.  
 Exposure to anthropogenic contaminants can result in changes in brain 
chemistry that can then affect an organism’s behavior.  If this relationship can be 
understood, scientists will be able to better predict the effects of these 
contaminants on organisms, leading to better management and regulation 
practices.  However, there have been very few studies that have been able to 
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successfully correlate organism behavior with brain chemistry.  As brain 
chemistry can be used to predict behavior, I plotted minnow behavior in the light-
dark behavioral bioassay as a function of neurotransmitter concentration.   
 Significant relationships were found between both behavioral endpoints 
and measured GABA and 5-HIAA concentrations after exposure to acute 
diazepam as well as between both behavioral endpoints and measured serotonin 
concentrations after exposure to long-term diazepam (Figs. 4.27-4.32).  
Diazepam was the only drug where a significant relationship between behavioral 
measures and neurotransmitters was observed.  Based on previous research, 
exposure to these anti-anxiety medications leads to an increase in number of 
entries to the light side and time spent on the light side, the two behavioral 
endpoints measured41,50.  I found that exposure to diazepam resulted in the 
display of anxiolytic behaviors by minnows on both an acute and long-term scale 
(Figs. 4.9 and 4.10).  In addition, exposure to these anti-anxiety medications can 
result in a decrease in circulating neurotransmitter levels, specifically those that 
regulate stress and anxiety, like serotonin and GABA36,37.  Studies investigating 
the effect of anti-anxiety medications on GABA, another stress-related 
neurotransmitter, are less reported.  I observed decreases in levels of three 
neurotransmitters after minnows were exposed to diazepam on both an acute 
and a long-term scale (Figs. 4.11 and 4.12).  Thus, I hypothesized that as 
minnow neurotransmitter levels decrease, minnows should enter the light side of 
the tank more and spend more time on the light side.  I found support for the 
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hypothesis in both GABA and 5-HIAA levels after minnows were exposed to 
acute diazepam.  As GABA and 5-HIAA levels in the brain decreased, minnows 
made more entries to the light side as well as spent significantly more time in the 
light.  However, although the relationship between these measures was found to 
be significant  in terms of 5-HIAA levels (p= 0.0274 and 0.0148, respectively), 
measured GABA and 5-HIAA levels seem to be weak predictors of minnow 
entries and time spent in the light, as the respective correlation coefficients 
0.148, 0.1617, 0.2023, and 0.2412 suggest.  The low correlation coefficients 
could be the result of a small sample size  as well as the inability to extract brains 
at all timepoints, leading to high variability and a lack of a dose-dependent trend 
in both the behavioral data as well as the brain data (Figs. 4.9-4.12).  In contrast, 
I found a weak, positive relationship between both log number of entries and log 
time spent in the light and measured serotonin levels after minnows were 
exposed to diazepam on a long-term scale.  As serotonin levels in the brain 
increased, minnows made more entries to the light side as well as spent more 
time in the light.  These results were the opposite of what was predicted: as 
serotonin levels in the brain decrease, minnows should enter the light side of the 
tank more and spend more time on the light side.  The relationship was 
significant despite the low correlation coefficients (R2=0.2159 and 0.1843).  Thus, 
a change in measured serotonin levels seems to be a weak predictor of minnow 
anxiety behavior after long-term exposure to diazepam.  Serotonin levels 
measured in minnows exposed to the highest concentration of diazepam were 
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higher than control minnows (Fig. 4.12) which could be an explanation as to why 
I observed a positive trend between behavioral endpoints and serotonin 
concentration rather than the predicted negative trend.  As diazepam is known to 
enhance the GABA-ergic system, it comes as no surprise that a weak 
relationship was found between anxiety behaviors and measured GABA 
concentrations.  Moreover, the weak relationships that were found between 
neurotransmitters involved in the serotonergic system and diazepam may spark 
more research on this drug as it has not been suggested that diazepam has any 
effect on the serotonergic system. 
 
 
 
 
 
 
 
 
 
 
 
93 
CHAPTER 5: CONCLUSIONS AND FUTURE DIRECTIONS 
 From this research, I can conclude the following: 
• Acute exposure to ethanol, a positive control for this behavioral assay, 
results in an anxiolytic effect in minnow behavior and brain chemistry at 
the onset of exposure, but a depressing effect as time goes on due to its 
nature as a sedative.   
• The most definitive results were observed after exposure to diazepam.  
Exposure to this drug will cause an anxiolytic effect on minnow behavior at 
high concentrations both acutely (one day) and on a long-term scale (nine 
days). 
• Fluoxetine exposure causes an anxiolytic effect in minnow behavior on an 
acute time scale, yet results in an overall increase in neurotransmitter 
concentrations both acutely and on a long-term scale as is supported by 
previous literature.   
• Overall, exposure to anti-anxiety drugs results in a decrease in 
neurotransmitter levels that may affect predator avoidance behaviors in 
fathead minnows.   
• Acute exposure to copper results in an anxiolytic effect on minnow 
behavior and a decrease in neurotransmitter levels as time passes and 
exposure concentrations increase.   
• The relationship between behavior and brain chemistry after chemical 
exposure can be further developed as evidenced by the significant, but 
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weak relationships that were found between minnow behavior and all 
measured neurotransmitter levels after exposure to diazepam.   
• Results from this study combined with further research will lead to better 
regulation of contaminants and management of susceptible species.        
 As stated above, one restriction of the experimental setup was the small 
sample size, which led to variability among replicates.  A larger sample size 
would offer the possibility of lower variability and more significant trends in the 
data as well as allow one to tease out the correlation between brain chemistry 
and behavior in minnows after exposure to contaminants.  A larger sample size 
would also allow brains to be extracted and analyzed after every timepoint during 
exposure.  In addition, the light-dark behavioral bioassay that was used in my 
experiments was developed for zebrafish.  Future exposures using this assay 
should be performed with zebrafish in order to understand some of the possible 
species differences.  Finally, there is a lack of research concerning the chronic 
effect of anti-anxiety medications on aquatic organisms.  Future studies should 
be aimed at determining the effects of these medications on aquatic organisms 
on a long-term scale.  Longer exposure times are more relevant as aquatic 
organisms are more likely to be exposed to sub-lethal doses of these drugs for 
an extended period of time rather than to acute doses.  These studies will 
provide researchers with additional insight on the fate and metabolism of these 
drugs in the aquatic environment.  Once scientists know more about how these 
drugs may affect aquatic organisms in the long-term, better management 
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practices and regulations may be passed for the use and disposal of anti-anxiety 
medications and other anthropogenic contaminants, leading to a healthier and 
safer environment for humans.    
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